Skip to main content
Top
Published in: Inflammation 2/2013

01-04-2013

Mycoplasma pneumoniae Extract Induces an IL-17-Associated Inflammatory Reaction in Murine Lung: Implication for Mycoplasmal Pneumonia

Authors: Daisuke Kurai, Kazuhide Nakagaki, Hiroo Wada, Takeshi Saraya, Shigeru Kamiya, Yasunori Fujioka, Koh Nakata, Hajime Takizawa, Hajime Goto

Published in: Inflammation | Issue 2/2013

Login to get access

Abstract

Mycoplasma pneumoniae (Mp) may cause immune cell reactions as pivotal aspects of this clinically common respiratory pathogen. Our aim is to determine if Mp extract induces a cellular immune response associated with interleukin (IL)-17, leading to lung inflammation and lung injury. BALB/c mice were immunized with Mp extract intraperitoneally followed by its intratracheal administration, to mimic repeated Mp infection found in humans (repeated inoculation, RI group). Those with a single inoculation were compared as single inoculation group (SI group). Analysis of bronchoalveolar lavage fluid (BALF) demonstrated that keratinocyte-derived cytokine, tumor necrosis factor-α, and IL-6 were produced and peaked on days 0.5 or 1, followed by IL-17 on day 2. Levels of these mediators in BALF were higher in RI group than SI group (P < 0.05). Further, significantly more neutrophils were recruited to the lungs of the RI group (P < 0.05). These observations suggest that IL-17 is involved in the prolonged induction of neutrophils in mice treated with Mp extract.
Literature
1.
go back to reference Waite, K.B., and D.F. Talkington. 2004. Mycoplasma pneumoniae and its role as a human pathogen. Clinical Microbiology Reviews 17: 697–728.CrossRef Waite, K.B., and D.F. Talkington. 2004. Mycoplasma pneumoniae and its role as a human pathogen. Clinical Microbiology Reviews 17: 697–728.CrossRef
2.
go back to reference Matsuoka, M., M. Narita, N. Okazaki, H. Ohya, T. Yamazaki, K. Ouchi, I. Suzuki, T. Andoh, T. Kenri, Y. Sasaki, A. Horino, M. Shintani, Y. Arakawa, and T. Sasaki. 2004. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical obtained in Japan. Antimicrobial Agents and Chemotherapy 48: 4624–4630.PubMedCrossRef Matsuoka, M., M. Narita, N. Okazaki, H. Ohya, T. Yamazaki, K. Ouchi, I. Suzuki, T. Andoh, T. Kenri, Y. Sasaki, A. Horino, M. Shintani, Y. Arakawa, and T. Sasaki. 2004. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical obtained in Japan. Antimicrobial Agents and Chemotherapy 48: 4624–4630.PubMedCrossRef
3.
go back to reference Opitz, O., K. Pietsch, S. Ehlers, and E. Jacobs. 1996–1997. Cytokine gene expression in immune mice reinfected with Mycoplasma pneumoniae: the role of T cell subsets in aggravating the inflammatory response. Immunobiology 196: 575–587.CrossRef Opitz, O., K. Pietsch, S. Ehlers, and E. Jacobs. 1996–1997. Cytokine gene expression in immune mice reinfected with Mycoplasma pneumoniae: the role of T cell subsets in aggravating the inflammatory response. Immunobiology 196: 575–587.CrossRef
4.
go back to reference British Thoracic Society Standards of Care Committee. 2002. BTS guidelines for the management of community acquired pneumonia in children. Thorax 57(Supple1): i1–i24. British Thoracic Society Standards of Care Committee. 2002. BTS guidelines for the management of community acquired pneumonia in children. Thorax 57(Supple1): i1–i24.
5.
go back to reference Fernald, G.W., A.M. Collier, and W.A. Clyde Jr. 1975. Respiratory infections due to Mycoplasma pneumoniae in infants and children. Pediatrics 55: 327–335.PubMed Fernald, G.W., A.M. Collier, and W.A. Clyde Jr. 1975. Respiratory infections due to Mycoplasma pneumoniae in infants and children. Pediatrics 55: 327–335.PubMed
6.
go back to reference Lim, W.S., S.V. Baudouin, R.C. George, A.T. Hill, C. Jamieson, I. Le Jeune, J.T. Macfarlane, R.C. Read, H.J. Roberts, M.L. Levy, M. Wani, M.A. Woodhead; Pneumonia Guidelines Committee of the BTS Standards of Care Committee. 2009. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 64(Suppl 3): iii1–55.CrossRef Lim, W.S., S.V. Baudouin, R.C. George, A.T. Hill, C. Jamieson, I. Le Jeune, J.T. Macfarlane, R.C. Read, H.J. Roberts, M.L. Levy, M. Wani, M.A. Woodhead; Pneumonia Guidelines Committee of the BTS Standards of Care Committee. 2009. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 64(Suppl 3): iii1–55.CrossRef
7.
go back to reference Steohen, G.B. Mycoplasma pneumoniae and atypical pneumonia In: Mandell, Douglas and Bennett's principle and principles and practice of infectious diseases. G.L. Mandell, J.E. Bennett, R. Dolin, editors. Philadelphia: Elsevier Inc., 2010: 2481–2489 Steohen, G.B. Mycoplasma pneumoniae and atypical pneumonia In: Mandell, Douglas and Bennett's principle and principles and practice of infectious diseases. G.L. Mandell, J.E. Bennett, R. Dolin, editors. Philadelphia: Elsevier Inc., 2010: 2481–2489
8.
go back to reference Smith, C.B., W.T. Friedewald, and R.M. Chanock. 1967. Inactivated Mycoplasma pneumoniae vaccine. Evaluation in volunteers. The Journal of the American Medical Association 199: 353–358.CrossRef Smith, C.B., W.T. Friedewald, and R.M. Chanock. 1967. Inactivated Mycoplasma pneumoniae vaccine. Evaluation in volunteers. The Journal of the American Medical Association 199: 353–358.CrossRef
9.
go back to reference Koh, Y.Y., Y. Park, H.J. Lee, and C.K. Kim. 2001. Levels of interleukin-2, interferon-γ, and interleukin-4 in bronchoalveolar lavage fluid from patients with Mycoplasma pneumonia: implication of tendency toward increased immunoglobulin E production. Pediatrics 107: E39.PubMedCrossRef Koh, Y.Y., Y. Park, H.J. Lee, and C.K. Kim. 2001. Levels of interleukin-2, interferon-γ, and interleukin-4 in bronchoalveolar lavage fluid from patients with Mycoplasma pneumonia: implication of tendency toward increased immunoglobulin E production. Pediatrics 107: E39.PubMedCrossRef
10.
go back to reference Nisar, N., R. Guleria, S. Kumar, T.C. Chawla, and N.R. Biswas. 2007. Mycoplasma pneumoniae and its role in asthma. Postgraduate Medical Journal 83: 100–104.CrossRef Nisar, N., R. Guleria, S. Kumar, T.C. Chawla, and N.R. Biswas. 2007. Mycoplasma pneumoniae and its role in asthma. Postgraduate Medical Journal 83: 100–104.CrossRef
11.
go back to reference Lee, K.Y., H.S. Lee, J.H. Hong, M.H. Lee, J.S. Lee, D. Burgner, and B.C. Lee. 2006. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children. Pediatric Pulmonology 41: 263–268.PubMedCrossRef Lee, K.Y., H.S. Lee, J.H. Hong, M.H. Lee, J.S. Lee, D. Burgner, and B.C. Lee. 2006. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children. Pediatric Pulmonology 41: 263–268.PubMedCrossRef
12.
go back to reference Radisic, M., A. Torn, P. Gutierrez, H.A. Defranchi, and P. Pardo. 2000. Severe acute lung injury caused by Mycoplasma pneumoniae: potential role for steroid pulses in treatment. Clinical Infectious Diseases 31: 1507–1511.PubMedCrossRef Radisic, M., A. Torn, P. Gutierrez, H.A. Defranchi, and P. Pardo. 2000. Severe acute lung injury caused by Mycoplasma pneumoniae: potential role for steroid pulses in treatment. Clinical Infectious Diseases 31: 1507–1511.PubMedCrossRef
13.
go back to reference Hirao, S., H. Wada, K. Nakagaki, T. Saraya, D. Kurai, S. Mikura, T. Yasutake, M. Higaki, T. Yokoyama, H. Ishii, K. Nakata, T. Aakashi, S. Kamiya, and H. Goto. 2011. Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone. FEMS Immunology and Medical Microbiology 62: 182–189.PubMedCrossRef Hirao, S., H. Wada, K. Nakagaki, T. Saraya, D. Kurai, S. Mikura, T. Yasutake, M. Higaki, T. Yokoyama, H. Ishii, K. Nakata, T. Aakashi, S. Kamiya, and H. Goto. 2011. Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone. FEMS Immunology and Medical Microbiology 62: 182–189.PubMedCrossRef
14.
go back to reference Saraya, T., K. Nakata, K. Nakagaki, N. Motoi, K. Iihara, Y. Fujioka, T. Oka, D. Kurai, H. Wada, H. Ishii, H. Taguchi, S. Kamiya, and H. Goto. 2011. Identification of a mechanism for lung inflammation caused by Mycoplasma pneumoniae using a novel mouse model. Results in Immunology 1: 76–87.CrossRef Saraya, T., K. Nakata, K. Nakagaki, N. Motoi, K. Iihara, Y. Fujioka, T. Oka, D. Kurai, H. Wada, H. Ishii, H. Taguchi, S. Kamiya, and H. Goto. 2011. Identification of a mechanism for lung inflammation caused by Mycoplasma pneumoniae using a novel mouse model. Results in Immunology 1: 76–87.CrossRef
15.
go back to reference Wu, Q., R.J. Martin, J.G. Rino, R. Breed, R.M. Torres, and H.W. Chu. 2007. IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes and Infection 9: 78–86.PubMedCrossRef Wu, Q., R.J. Martin, J.G. Rino, R. Breed, R.M. Torres, and H.W. Chu. 2007. IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. Microbes and Infection 9: 78–86.PubMedCrossRef
16.
go back to reference Michelow, I.C., K. Katz, G.H. McCracken, and R.D. Hardy. 2007. Systemic cytokine profile in children with community-acquired pneumonia. Pediatric Pulmonology 42: 640–645.PubMedCrossRef Michelow, I.C., K. Katz, G.H. McCracken, and R.D. Hardy. 2007. Systemic cytokine profile in children with community-acquired pneumonia. Pediatric Pulmonology 42: 640–645.PubMedCrossRef
17.
go back to reference Pridgeon, C., L. Bugeon, L. Donnelly, U. Straschil, S.J. Tudhope, P. Fenwick, J.R. Lamb, P.J. Barnes, and M.J. Dallman. 2011. Regulation of IL-17 in chronic inflammation in the human lung. Clinical Science 120: 515–524.PubMedCrossRef Pridgeon, C., L. Bugeon, L. Donnelly, U. Straschil, S.J. Tudhope, P. Fenwick, J.R. Lamb, P.J. Barnes, and M.J. Dallman. 2011. Regulation of IL-17 in chronic inflammation in the human lung. Clinical Science 120: 515–524.PubMedCrossRef
18.
go back to reference Vanaudenaerde, B.M., S.E. Verleden, R. De, S.I. Vos, A. Vleeschauwer, R. Willems-Widyastuti, D.E.Van Geenens, L.J. Raemdonck, E.K. Dupont, and I.Meyts Verbeken. 2011. Innate and adaptive interleukin-17-producing lymphocytes in chronic inflammatory lung disorders. American Journal of Respiratory and Critical Care Medicine 183: 977–986.PubMedCrossRef Vanaudenaerde, B.M., S.E. Verleden, R. De, S.I. Vos, A. Vleeschauwer, R. Willems-Widyastuti, D.E.Van Geenens, L.J. Raemdonck, E.K. Dupont, and I.Meyts Verbeken. 2011. Innate and adaptive interleukin-17-producing lymphocytes in chronic inflammatory lung disorders. American Journal of Respiratory and Critical Care Medicine 183: 977–986.PubMedCrossRef
19.
go back to reference Bettelli, E., T. Korn, M. Oukka, and V.K. Kuchroo. 2008. Induction and effector functions of T(H)17 cells. Nature 453: 1051–1057.PubMedCrossRef Bettelli, E., T. Korn, M. Oukka, and V.K. Kuchroo. 2008. Induction and effector functions of T(H)17 cells. Nature 453: 1051–1057.PubMedCrossRef
20.
go back to reference Mills, K.H. 2008. Induction, function and regulation of IL-17-producing T cells. European Journal of Immunology 38: 2636–2649.PubMedCrossRef Mills, K.H. 2008. Induction, function and regulation of IL-17-producing T cells. European Journal of Immunology 38: 2636–2649.PubMedCrossRef
21.
go back to reference Shen, N., J. Wang, M. Zhao, F. Pei, and B. He. 2011. Anti-interleukin-17 antibodies attenuate airway inflammation in tobacco-smoke-exposed mice. Inhal Toxicol 23: 212–218.PubMedCrossRef Shen, N., J. Wang, M. Zhao, F. Pei, and B. He. 2011. Anti-interleukin-17 antibodies attenuate airway inflammation in tobacco-smoke-exposed mice. Inhal Toxicol 23: 212–218.PubMedCrossRef
22.
go back to reference Chmura, K., X. Bai, M. Nakamura, P. Kandasamy, M. McGibney, K. Kuronuma, H. Mitsuzawa, D.R. Voelker, and E.D. Chan. 2008. Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells. American Journal of Physiology - Lung Cellular and Molecular Physiology 295: L220–L230.PubMedCrossRef Chmura, K., X. Bai, M. Nakamura, P. Kandasamy, M. McGibney, K. Kuronuma, H. Mitsuzawa, D.R. Voelker, and E.D. Chan. 2008. Induction of IL-8 by Mycoplasma pneumoniae membrane in BEAS-2B cells. American Journal of Physiology - Lung Cellular and Molecular Physiology 295: L220–L230.PubMedCrossRef
23.
go back to reference Sohn, M.H., K.E. Lee, S.Y. Choi, B.C. Kwon, M.W. Chang, and K.E. Kim. 2005. Effect of Mycoplasma pneumoniae lysate on interleukin-8 gene expression in human respiratory epithelial cells. Chest 128: 322–326.PubMedCrossRef Sohn, M.H., K.E. Lee, S.Y. Choi, B.C. Kwon, M.W. Chang, and K.E. Kim. 2005. Effect of Mycoplasma pneumoniae lysate on interleukin-8 gene expression in human respiratory epithelial cells. Chest 128: 322–326.PubMedCrossRef
24.
go back to reference Ferretti, S., O. Bonneau, G.R. Dubois, C.E. Jones, and A. Trifilieff. 2003. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. The Journal of Immunology 170: 2106–2112.PubMed Ferretti, S., O. Bonneau, G.R. Dubois, C.E. Jones, and A. Trifilieff. 2003. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. The Journal of Immunology 170: 2106–2112.PubMed
25.
go back to reference Hartupee, J., C. Liu, M. Novotny, X. Li, and T. Hamilton. 2007. IL-17 enhances chemokine gene expression through mRNA stabilization. The Journal of Immunology 179: 4135–4141.PubMed Hartupee, J., C. Liu, M. Novotny, X. Li, and T. Hamilton. 2007. IL-17 enhances chemokine gene expression through mRNA stabilization. The Journal of Immunology 179: 4135–4141.PubMed
26.
go back to reference Chu, H.W., R. Breed, J.G. Rino, R.J. Harbeck, M.R. Sills, and R.J. Martin. 2006. Repeated respiratory Mycoplasma pneumoniae infections in mice: effect of host genetic background. Microbes and Infection 8: 1764–1772.PubMedCrossRef Chu, H.W., R. Breed, J.G. Rino, R.J. Harbeck, M.R. Sills, and R.J. Martin. 2006. Repeated respiratory Mycoplasma pneumoniae infections in mice: effect of host genetic background. Microbes and Infection 8: 1764–1772.PubMedCrossRef
27.
go back to reference Fonseca-Aten, M., A.M. Ríos, A. Mejías, S. Chávez-Bueno, K. Katz, A.M. Gomez, G.H. McCracken Jr., and R.D. Hardy. 2005. Mycoplasma pneumoniae induces host-dependent pulmonary inflammation and airway obstruction in mice. American Journal of Physiology - Lung Cellular and Molecular Physiology 32: 201–210. Fonseca-Aten, M., A.M. Ríos, A. Mejías, S. Chávez-Bueno, K. Katz, A.M. Gomez, G.H. McCracken Jr., and R.D. Hardy. 2005. Mycoplasma pneumoniae induces host-dependent pulmonary inflammation and airway obstruction in mice. American Journal of Physiology - Lung Cellular and Molecular Physiology 32: 201–210.
28.
go back to reference Salvatore, C.M., M. Fonseca-Aten, K. Katz-Gaynor, A.M. Gomez, A. Mejias, C. Somers, S. Chavez-Bueno, G.H. McCracken, and R.D. Hardy. 2007. Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation. Infection and Immunity 75: 236–242.PubMedCrossRef Salvatore, C.M., M. Fonseca-Aten, K. Katz-Gaynor, A.M. Gomez, A. Mejias, C. Somers, S. Chavez-Bueno, G.H. McCracken, and R.D. Hardy. 2007. Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation. Infection and Immunity 75: 236–242.PubMedCrossRef
29.
go back to reference Salvatore, C.M., M. Fonseca-Aten, K. Katz-Gaynor, A.M. Gomez, and R.D. Hardy. 2008. Intranasal interleukin-12 therapy inhibits Mycoplasma pneumoniae clearance and sustains airway obstruction in murine pneumonia. Infection and Immunity 76: 732–738.PubMedCrossRef Salvatore, C.M., M. Fonseca-Aten, K. Katz-Gaynor, A.M. Gomez, and R.D. Hardy. 2008. Intranasal interleukin-12 therapy inhibits Mycoplasma pneumoniae clearance and sustains airway obstruction in murine pneumonia. Infection and Immunity 76: 732–738.PubMedCrossRef
Metadata
Title
Mycoplasma pneumoniae Extract Induces an IL-17-Associated Inflammatory Reaction in Murine Lung: Implication for Mycoplasmal Pneumonia
Authors
Daisuke Kurai
Kazuhide Nakagaki
Hiroo Wada
Takeshi Saraya
Shigeru Kamiya
Yasunori Fujioka
Koh Nakata
Hajime Takizawa
Hajime Goto
Publication date
01-04-2013
Publisher
Springer US
Published in
Inflammation / Issue 2/2013
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-012-9545-3

Other articles of this Issue 2/2013

Inflammation 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.